通过专为投资者打造的一站式数据看板，全面查看 Revolution Medicines Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

43.91B

股息TTM

0.00

市盈率 TTM

-28.84

每股收益TTM

-7.11

营业收入

0.00

净利润

-600.09M

净资产收益率

-76.67%

总资产收益率

-59.39%

Revolution Medicines Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

-132.54%-3.06

-101.96%-2.29

-67.95%-1.88

-72.18%-1.61

-62.86%-1.31

-61.08%-1.13

2.18%-1.12

5.64%-0.94

12.28%-0.81

1.93%-0.70

-80.33%-1.14

---0.99

---0.92

---0.72

---0.63

---2.47

----

营业收入

----

--0.00

----

-100.00%0.00

--0.00

-100.00%0.00

-95.16%742.00K

-100.00%0.00

-58.05%3.82M

-7.44%7.01M

62.05%15.33M

204.81%3.36M

4.81%9.12M

-25.20%7.58M

8.10%9.46M

-91.30%1.10M

净利润

-160.05%-644.37M

-112.64%-453.82M

-87.54%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-20.45%-194.57M

-44.13%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.30M

-18.13%-68.10M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

-55.07%-57.65M

-54.01%-52.68M

-94.48%-52.94M

利润率

----

-5806.20%-21770.49%

----

---2570.55%

---970.89%

---368.60%

---958.59%

----

毛利率

----

0.00%100.00%

----

--100.00%

----

资产负债率

--23.96%

--12.45%

--11.40%

--11.39%

----

利润表

营业收入

----

--0.00

----

-100.00%0.00

--0.00

-100.00%0.00

-95.16%742.00K

-100.00%0.00

-58.05%3.82M

-7.44%7.01M

62.05%15.33M

204.81%3.36M

4.81%9.12M

-25.20%7.58M

8.10%9.46M

-91.30%1.10M

营业利润

-90.82%-505.13M

-84.92%-445.22M

-67.18%-361.63M

-79.42%-315.27M

-68.99%-264.71M

-70.92%-240.76M

-20.18%-216.31M

-42.57%-175.71M

-43.98%-156.64M

-87.42%-140.86M

-191.67%-179.98M

-61.04%-123.25M

-75.23%-108.80M

-29.70%-75.16M

-16.62%-61.71M

-43.96%-76.53M

-39.42%-62.09M

-54.96%-57.95M

-55.26%-52.91M

-92.96%-53.16M

净利润

-160.05%-644.37M

-112.64%-453.82M

-87.54%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-20.45%-194.57M

-44.13%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.30M

-18.13%-68.10M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

-55.07%-57.65M

-54.01%-52.68M

-94.48%-52.94M

资产负债表

流动资产

85.09%4.03B

-7.81%1.97B

-10.85%2.08B

25.23%1.98B

33.96%2.18B

23.44%2.13B

23.86%2.33B

91.53%1.58B

76.20%1.62B

87.40%1.73B

184.66%1.88B

22.12%824.47M

90.89%922.09M

72.69%922.75M

11.94%660.18M

8.27%675.11M

-26.92%483.05M

-23.38%534.34M

29.87%589.77M

29.12%623.54M

流动负债总额

91.87%354.06M

82.60%289.60M

77.18%290.42M

121.55%245.62M

75.19%184.53M

69.22%158.60M

13.95%163.91M

29.60%110.86M

34.94%105.33M

71.54%93.72M

132.08%143.85M

16.75%85.54M

22.85%78.06M

-4.91%54.63M

2.71%61.98M

41.20%73.27M

38.73%63.54M

31.31%57.46M

27.93%60.35M

22.43%51.89M

总资产

77.94%4.32B

-4.72%2.25B

-7.97%2.35B

27.73%2.25B

34.35%2.43B

23.95%2.37B

24.09%2.56B

79.12%1.76B

68.43%1.81B

77.81%1.91B

153.93%2.06B

19.17%984.23M

69.68%1.07B

57.19%1.07B

10.02%811.93M

12.37%825.91M

-18.25%632.80M

-15.88%682.77M

30.06%737.99M

23.51%734.98M

总负债

204.33%1.72B

162.47%753.82M

146.75%723.21M

233.01%655.02M

197.59%564.20M

57.03%287.20M

24.45%293.10M

34.01%196.69M

32.70%189.59M

51.12%182.90M

85.82%235.51M

1.58%146.77M

6.65%142.87M

-8.16%121.03M

-6.41%126.74M

49.31%144.49M

50.45%133.96M

47.95%131.78M

46.04%135.42M

7.52%96.77M

总权益

39.72%2.61B

-27.82%1.50B

-27.98%1.63B

1.95%1.60B

15.23%1.87B

20.44%2.08B

24.04%2.27B

87.03%1.57B

73.91%1.62B

81.21%1.73B

166.52%1.83B

22.90%837.46M

86.60%930.84M

72.82%952.22M

13.71%685.19M

6.77%681.42M

-27.18%498.84M

-23.75%550.99M

26.94%602.57M

26.36%638.20M

现金流量表

经营净额

-74.66%-387.32M

-82.15%-354.17M

-98.31%-274.24M

-58.96%-207.31M

-73.02%-221.76M

-21.10%-194.44M

-14.70%-138.29M

-29.77%-130.42M

-90.95%-128.17M

-157.34%-160.56M

-95.12%-120.56M

-94.25%-100.50M

-20.47%-67.12M

-13.11%-62.39M

-57.36%-61.79M

-41.40%-51.74M

-63.48%-55.72M

-48.10%-55.16M

-56.85%-39.27M

-35.41%-36.59M

投资净额

-4939.16%-1.66B

1182.29%172.62M

119.06%74.88M

215.74%24.85M

-68.25%34.28M

93.57%-15.95M

-3.29%-392.90M

-127.75%-21.47M

347.90%107.94M

-6305.36%-247.97M

-5254.76%-380.40M

162.66%77.35M

-169.78%-43.54M

-90.92%4.00M

-183.25%-7.10M

-309.05%-123.44M

150.82%62.40M

1806.67%44.02M

-86.44%8.53M

70.11%-30.18M

融资净额

843.35%2.42B

27216.25%238.74M

-58.15%365.66M

-102.06%-1.59M

3319.28%256.58M

7.90%874.00K

4.10%873.80M

7545.30%77.29M

-88.39%7.50M

-99.75%810.00K

1534.16%839.35M

-99.59%1.01M

4422.74%64.63M

106196.72%324.20M

378.78%51.36M

77747.96%248.34M

64.63%1.43M

-99.89%305.00K

622.42%10.73M

-99.81%319.00K

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

Revolution Medicines Inc的流动资产是多少？



根据Revolution Medicines Inc的FY2025财报，流动资产为2.08B（同比变化-10.85）。

Revolution Medicines Inc的总资产是多少？



根据Revolution Medicines Inc的FY2025财报，Revolution Medicines Inc的总资产为2.35B（同比变化-7.97）。

Revolution Medicines Inc的总负债是多少？



根据Revolution Medicines Inc的FY2025财报，Revolution Medicines Inc的总负债为723.21M（同比变化146.75）。

Revolution Medicines Inc的总权益是多少？



根据Revolution Medicines Inc的FY2025财报，Revolution Medicines Inc的总权益为1.63B（同比变化-27.98）。

Revolution Medicines Inc的净营业收入是多少？



根据Revolution Medicines Inc的FY2025财报，Revolution Medicines Inc的净营业收入为-1.18B（同比变化-71.48）。

Revolution Medicines Inc的净投资是多少？



根据Revolution Medicines Inc的FY2025财报，Revolution Medicines Inc的净投资为118.06M（同比变化121.29）。

Revolution Medicines Inc的净融资是多少？



根据Revolution Medicines Inc的FY2025财报，Revolution Medicines Inc的净融资为621.52M（同比变化-35.22）。

Revolution Medicines Inc的每股收益（EPS）是多少？



根据Revolution Medicines Inc的FY2025财报，每股收益（EPS）为-5.95（同比变化-66.32）。

Revolution Medicines Inc的净利润是多少？



根据Revolution Medicines Inc的FY2025财报，净利润为-1.13B（同比变化-88.52）。

Revolution Medicines Inc的股东权益回报率（ROE）是多少？



根据Revolution Medicines Inc的FY2025财报，股东权益回报率（ROE）为-58.07（同比变化-97.95）。

Revolution Medicines Inc的资产回报率（ROA）是多少？



根据Revolution Medicines Inc的FY2025财报，资产回报率（ROA）为-46.06（同比变化-77.29）。

Revolution Medicines Inc的营业利润是多少？



根据Revolution Medicines Inc的FY2025财报，营业利润为-1.18B（同比变化-71.48）。